Mucinous colorectal adenocarcinoma: Clinicopathological features, molecular profiling, and therapeutic challenges
Mucinous colorectal adenocarcinoma (MAC) accounts for approximately 10% of all colorectal cancers and is defined by the presence of extracellular mucin in more than 50% of the tumour volume. The prognosis of MAC compared with non-mucinous colorectal adenocarcinoma remains debated, with reported outcomes influenced by tumour stage, location and molecular characteristics. MAC is frequently diagnosed at a more advanced stage, exhibits increased lymph node involvement and a greater tendency towards peritoneal metastases, and has been associated with reduced response to neoadjuvant chemoradiotherapy, particularly in rectal cancer. Moreover, mucinous differentiation is associated with distinct clinicopathological, molecular and epigenetic features, including higher frequencies of microsatellite instability (MSI), CpG island methylator phenotype (CIMP) and BRAF mutations. Nevertheless, current clinical guidelines do not provide separate treatment recommendations for this histological subtype, and management remains guided by disease stage, resectability and established molecular biomarkers. In this review, we explore the current literature to summarise the epidemiology and prognosis, distinct clinicopathological features, molecular characteristics, diagnostic techniques and management of MAC, including recent advances in surgical treatment, targeted molecular therapy and immunotherapy. As our understanding of the molecular biology of mucinous colorectal adenocarcinoma continues to evolve, advances in molecular profiling may facilitate more precise risk stratification and the development of targeted and personalised treatment approaches.
Authors
- Athina Anagnou
- Theodora Pissanou
- Μιλτιάδης Καστανάκης
- Chrysanthi Simou (ORCID: https://orcid.org/0000-0001-7944-9537)
- Evangelos Lolis (ORCID: https://orcid.org/0000-0002-0944-4770)
- Giorgos Tsismenakis
Institutions
- Royal Free London NHS Foundation Trust (GB)
- The Royal Free Hospital (GB)
- Chania General Hospital ”St. George” (GR)
- University Hospital of Ioannina (GR)
Publication Details
- Journal
- Surgical Oncology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1016/j.suronc.2026.102612
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00